Excelsyn Ltd @ InformEx USA 2010, stand 1334

Published: 10-Feb-2010

Excelsyn is an experienced chemistry services provider to the biotechnology and pharmaceutical industries. We offer a broad range of cost-effective integrated services to support drug candidate development from optimised lead through to commercial production, including synthetic route evaluation, process development, scale-up and production from grams to tonnes.
The success of Excelsyn and the strong customer relationships is demonstrated by:
A global reach to customers in Europe and US
A repeat business rate of 75%
An enquiry to deal rate of 35% for new opportunities
The key to our success is achieved by:
Problem solving
Flexibility
Speed
Cost focus
  • Companies:
  • Informa
See more

You may also like

Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Read more
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

CPHI & PMEC China sees surge in international attendance as globalpharma trade outlook strengthens

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing,as easing tariffs fuel growth
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Of data, devices and drug delivery

Ahead of Pharmapack Europe 2025 (22–23January, Paris, France), Dr Kevin Robinson (KSR) spoke with three pharma leaders about the big trends that will drive and influence the pharmaceutical sector in 2025
Manufacturing

Faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act, states CPHI Milan survey

CPHI Milan returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025
Pharmaceutical

CPHI Milan announces the finalists for 14 categories of the Pharma Awards

Awards for future leaders, women of the year and those at the heart of pharma will be handed out at the CPHI Pharma Awards ceremony
Ingredients

CPHI Milan Annual Report 2024

Ahead of next month’s CPHI Milan — where the industry is expected to turnout in record numbers with a staggering 62,000 pharma executives expected from more than 100 countries — Manufacturing Chemist got a sneak preview of the CPHI Annual Reports Excipients Analysis featuring Ian Moore’s (former Chair of the IPEC Europe GMP Committee) personal predictions for the year ahead
Manufacturing

Rapid increase in purchasing teams expected at CPHI North America

Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
Packaging

Contract packaging predicted to see high growth in 2024 ahead of Pharmapack Europe

Ninety four per cent of the industry are either "highly positive" or "moderately positive" about growth prospects for 2024
Subscribe now